This review summarizes the pathogenesis of endothelial dysfunction in Type 2 diabetes and reiterates that adding niacin to statin therapy is not beneficial for patients with well-controlled LDL-C.
No takes yet. Share an insight, caveat, or question.
Endothelial dysfunction assessment may refine CV risk prediction in diabetes; leaves open optimal low-HDL-C strategies on statins.
Hamilton et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: